• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Pliant Therapeutics, Inc. - Common Stock (NQ:PLRX)

1.040 -0.020 (-1.89%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 31, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Pliant Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
News headline image
Pliant Therapeutics Announces Positive Safety and Exploratory Efficacy Data from Phase 2a INTEGRIS-PSC Clinical Trial of Bexotegrast in Patients with Primary Sclerosing Cholangitis and Suspected Liver Fibrosis
September 26, 2023
From Pliant Therapeutics, Inc.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
September 25, 2023
 
Via Benzinga
News headline image
Pliant Therapeutics to Host Investor Call and Webcast to Discuss Interim Results from INTEGRIS-PSC, a Phase 2a Trial in Patients with Primary Sclerosing Cholangitis
September 25, 2023
From Pliant Therapeutics, Inc.
Via GlobeNewswire
News headline image
Expert Ratings for Pliant Therapeutics ↗
September 15, 2023
 
Via Benzinga
News headline image
Where Pliant Therapeutics Stands With Analysts ↗
August 22, 2023
 
Via Benzinga
News headline image
Expert Ratings for Pliant Therapeutics ↗
May 18, 2023
 
Via Benzinga
News headline image
Recap: Pliant Therapeutics Q1 Earnings ↗
May 09, 2023
 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Friday ↗
September 15, 2023
  Friday's session saw 169 companies set new 52-week lows. 
Via Benzinga
News headline image
Pliant Therapeutics Appoints Minnie Kuo as Chief Development Officer
September 15, 2023
From Pliant Therapeutics, Inc.
Via GlobeNewswire
News headline image
What 12 Analyst Ratings Have To Say About Pliant Therapeutics ↗
May 02, 2023
 
Via Benzinga
News headline image
Pliant Therapeutics Shares Fall After Long-Term Data Of Bexotegrast In Lung Fibrosis Study ↗
May 01, 2023
 
Via Benzinga
News headline image
Pliant Therapeutics Announces Presentations at the European Respiratory Society International Congress 2023
September 11, 2023
From Pliant Therapeutics, Inc.
Via GlobeNewswire
News headline image
IPF Has A 0% Survival Rate Without Lung Transplant And A Median Survival Time Of 2-5 Years From Diagnosis – Could GRI-0621 Be The Solution? ↗
August 31, 2023
Idiopathic Pulmonary Fibrosis (IPF) is a serious chronic lung disease characterized by the thickening and stiffening of the lung tissue surrounding the air sacs. The exact cause of IPF is unknown, but... 
Via Benzinga
News headline image
Pliant Therapeutics to Participate in Upcoming Investor Conferences
August 30, 2023
From Pliant Therapeutics, Inc.
Via GlobeNewswire
News headline image
Pliant Therapeutics Announces Three Upcoming Presentations at the European Respiratory Society International Congress 2023
August 28, 2023
From Pliant Therapeutics, Inc.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
August 17, 2023
 
Via Benzinga
News headline image
Pliant Therapeutics Provides Corporate Update and Reports Second Quarter 2023 Financial Results
August 09, 2023
From Pliant Therapeutics, Inc.
Via GlobeNewswire
News headline image
Pliant Therapeutics Announces Initiation of BEACON-IPF, a Phase 2b Clinical Trial of Bexotegrast in Idiopathic Pulmonary Fibrosis
August 09, 2023
Follows positive data from INTEGRIS-IPF Phase 2a trial 
From Pliant Therapeutics, Inc.
Via GlobeNewswire
News headline image
Pliant Therapeutics to Participate in Upcoming Investor Conferences
July 25, 2023
From Pliant Therapeutics, Inc.
Via GlobeNewswire
News headline image
Pliant Therapeutics Presents Data from its Bexotegrast Program at the European Association for the Study of the Liver (EASL) International Liver Congress™
June 23, 2023
Presentations highlight preclinical and clinical advancements of bexotegrast program in primary sclerosing cholangitis 
From Pliant Therapeutics, Inc.
Via GlobeNewswire
News headline image
Pliant Therapeutics Presents Data from its Bexotegrast Program at the American Thoracic Society International Conference
May 24, 2023
From Pliant Therapeutics, Inc.
Via GlobeNewswire
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For May 18, 2023 ↗
May 18, 2023
 
Via Benzinga
News headline image
Pliant Therapeutics to Participate in Upcoming Investor Events
May 10, 2023
From Pliant Therapeutics, Inc.
Via GlobeNewswire
News headline image
Pliant Therapeutics Provides Corporate Update and Reports First Quarter 2023 Financial Results
May 09, 2023
From Pliant Therapeutics, Inc.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
May 01, 2023
 
Via Benzinga
News headline image
First Republic Bank, Top Financial And Other Big Stocks Moving Lower On Monday ↗
May 01, 2023
U.S. stocks traded lower, with the Nasdaq falling around 17 points on Monday. Here are some big stocks recording losses in today’s session. 
Via Benzinga
News headline image
US Stocks Rise; Norwegian Cruise Line Posts Q1 Results ↗
May 01, 2023
U.S. stocks traded higher this morning, ahead of the Federal Reserve’s monetary policy meeting. Following the market opening Monday, the Dow traded up 0.15% to 34,147.97, while the NASDAQ inched up... 
Via Benzinga
News headline image
Why First Republic Bank Shares Are Trading Lower By 34%; Here Are 20 Stocks Moving Premarket ↗
May 01, 2023
Gainers Hongli Group Inc. (NASDAQ: HLP) gained 317.8% to $17.55 in pre-market trading. Hongli Group recently announced pricing of $8.25 million initial public offering of 2,062,500 ordinary shares at a... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
May 01, 2023
 
Via Benzinga
News headline image
Pliant Therapeutics Announces Positive Long-Term Data from the INTEGRIS-IPF Phase 2a Trial Demonstrating Bexotegrast was Well Tolerated at 320 mg with Durable Improvement Shown in FVC and Across Multiple Measures
April 30, 2023
From Pliant Therapeutics, Inc.
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap